Scans could help tailor pancreatic cancer treatment

February 12, 2018, Cancer Research UK
Scans could help tailor pancreatic cancer treatment
Credit: Cancer Research UK

Doctors should use a specialised type of scan to help decide if patients with pancreatic cancer may benefit from surgery, according to the National Institute for Health and Care Excellence (NICE).

New guidance from NICE says a PET-CT scan should be used early in the process of diagnosing pancreatic . It is thought that the scans will give doctors more on how advanced the disease is.

Professor Mark Baker, director of the centre for guidelines at NICE, said giving the PET-CT scan could have a significant impact on the treatment of patients with pancreatic cancer.

"It will mean that the staging process is more effective so that patients stand a better chance of getting the right treatment, at the right time," he said.

Deciding on treatment

Around 9,600 people in the UK are diagnosed with pancreatic cancer each year and survival is stubbornly low.

Surgery is most effective for patients if their disease has been diagnosed early.

NICE estimates that using the PET-CT scan to determine the stage of pancreatic cancer will reduce the number of NHS surgeries to remove these tumours by around 20%. This means that patients with more advanced pancreatic cancer will not undergo surgery that they are unlikely to benefit from.

This would help limit the side effects of surgery. And NICE said those who are not suitable for surgery will then be able to access chemotherapy treatment sooner.

It could also then free up theatre time for other patients.

Professor Andrew Biankin, Cancer Research UK's pancreatic cancer expert, approved of the new guidelines and said they were "an important step forward in making treatment selection for cancer patients more precise."

How does a PET-CT work?

A PET-CT scan is a type of imaging machine that combines a CT scan and a PET scan. It gives doctors detailed information about a person's cancer, including the size of the tumour and whether it has spread.

The CT scan takes a series of x-rays around the body and the PET scan uses a radioactive drug to highlight areas in the body where cells are more active than normal.

Biankin added that more research was needed to look at how to better personalise treatment.

"We now need to work on better ways to select the best for an individual, which will require testing and imaging at a molecular level," he said.

"At Cancer Research UK, our Flagship Programme PRECISION Panc, based in Glasgow, is working on ways to do just that.

"This programme aims to find the right clinical trial for the patient by offering cutting edge molecular testing of their cancer. The patient can then take part in a trial that's testing out new drugs that better match their individual tumour."

Explore further: A groundbreaking pancreatic cancer trial aims to match patients with more targeted and effective treatm

More information: Paula Ghaneh et al. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer, Health Technology Assessment (2018). DOI: 10.3310/hta22070

Related Stories

A groundbreaking pancreatic cancer trial aims to match patients with more targeted and effective treatm

December 5, 2017
A ground-breaking new pancreatic cancer trial, which aims to match patients with more targeted and effective treatment for their tumours, is to begin in Scotland.

New era in precision medicine for pancreatic cancer

March 23, 2017
The development of new treatments for pancreatic cancer is set to be transformed by a network of clinical trials, aiming to find the right trial for the right patient, after a £10 million investment from Cancer Research ...

Narrowing the gap toward precision medicine for pancreatic cancer

January 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center's Jen Jen Yeh, MD, is working to understand the complicated relationship between one of the deadliest cancers and the web of connective tissue that can surround ...

Do pancreatic cysts become cancerous?

November 21, 2017
What is a pancreatic cyst?

Pancreatic cancer trial to make tumours more sensitive to treatment

August 30, 2016
Cancer Research UK (CRUK) launches a first-of-its-kind pancreatic cancer clinical trial to make cancer cells more responsive to chemotherapy and radiotherapy, with University of Glasgow researcher Professor Jeff Evans as ...

Scientists link pancreatic cancer survival to four genes

November 3, 2017
Alterations in four main genes are responsible for how long patients survive with pancreatic cancer, according to a new study in JAMA Oncology.

Recommended for you

New antibody breakthrough to lead the fight against cancer

November 14, 2018
Scientists at the University of Southampton have developed a new antibody that could hold the key to unlocking cancer's defence against the body's immune system.

Photoacoustic imaging may help doctors detect ovarian tumors earlier

November 14, 2018
Ovarian cancer claims the lives of more than 14,000 in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University in St. Louis has found an innovative way to use sound ...

Solving the mystery of NPM1 in acute myeloid leukemia

November 13, 2018
Although it has long been recognized that mutations of gene NPM1 play an important role in acute myeloid leukemia, no one has determined how the normal and the mutated forms of the protein NPM1 function.

Cognitive decline—radiation—brain tumor prevented by temporarily shutting down immune response

November 13, 2018
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly ...

Study finds promising therapeutic target for aggressive type of breast cancer

November 13, 2018
A new Nature Communications study led by University of Kentucky Markey Cancer Center researchers suggests that an enzyme known as Prolyl 4-hydroxylase subunit alpha-1 (P4HA1) is a potential therapeutic target for triple negative ...

Scientists shine new light on link between obesity and cancer

November 12, 2018
Scientists have made a major discovery that shines a new, explanatory light on the link between obesity and cancer. Their research confirms why the body's immune surveillance systems—led by cancer-fighting Natural Killer ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.